1. Home
  2. companies
  3. JNJ

JNJ

Novartis' psoriasis drug tops J&J's Stelara as it speeds toward approval
Novartis' psoriasis drug tops J&J's Stelara as it speeds toward approval
Fierce Biotech
Novartis
psoriasis
JNJ
Stelara
secukinumab
One shot or two? Many questions unresolved in Ebola vaccine race
One shot or two? Many questions unresolved in Ebola vaccine race
Yahoo/Reuters
ebola virus
vaccines
GSK
NewLink Genetics
JNJ
Merck
Covidien Loses $176M Award in Patent Case Against JNJ Unit
Covidien Loses $176M Award in Patent Case Against JNJ Unit
Yahoo/Zacks.com
Covidien
patents
JNJ
devices
Ethicon
Update: FDA Clears Johnson & Johnson's Insulin Pump, An Artificial Pancreas Quickened
Update: FDA Clears Johnson & Johnson's Insulin Pump, An Artificial Pancreas Quickened
Seeking Alpha
FDA
devices
diabetes
JNJ
insulin pump
Animas Vibe
artificial pancreas
U.S. appeals court tosses $176 mln award for Covidien in patent case
U.S. appeals court tosses $176 mln award for Covidien in patent case
Yahoo/Reuters
Covidien
JNJ
Dune Medical Devices
JNJ launches PhII lymphoma study for daratumumab
JNJ launches PhII lymphoma study for daratumumab
Fierce Biotech
JNJ
lymphoma
daratumumab
Genmab
non-Hodgkin's lymphoma
Johnson & Johnson Bought Alios for Hepatitis C
Johnson & Johnson Bought Alios for Hepatitis C
Motley Fool
JNJ
Alios BioPharma
M&A
hepatitis C
J&J looks for Xarelto boost in real-world cost data
J&J looks for Xarelto boost in real-world cost data
Fierce Pharma Marketing
JNJ
Xarelto
bloodthinners
J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III
J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III
Fierce Biotech
JNJ
Astellas
rheumatoid arthritis
ASP015K
JAK inhibitors
J&J bets up to $277M on a prospect from its R&D farm system
J&J bets up to $277M on a prospect from its R&D farm system
Fierce Biotech
JNJ
R&D
Modern Biosciences
Who are the stars of personalized medicine? Roche, Novartis and J&J
Who are the stars of personalized medicine? Roche, Novartis and J&J
Fierce Pharma Marketing
personalized medicine
Roche
Novartis
JNJ
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Fierce Biotech
Amgen
AstraZeneca
brodalumab
JNJ
Stelara
psoriasis
J&J hopes third time is the charm for antitumor agent Yondelis
J&J hopes third time is the charm for antitumor agent Yondelis
Fierce Biotech
JNJ
Yondelis
ovarian cancer
JNJ, Transposagen To Co-Develop CAR-T Therapy
JNJ, Transposagen To Co-Develop CAR-T Therapy
Bidness Etc.
JNJ
Transposagen
CAR-T
cancer immunotherapy
FDA tightens guidelines on technique for uterine fibroid surgery
FDA tightens guidelines on technique for uterine fibroid surgery
Yahoo/Reuters
FDA
uterine fibroids
devices
Ethicon
JNJ
laparoscopic power morcellators
Johnson & Johnson (JNJ) Strikes $935 Million Deal With Geron Corporation (GERN) To Co-Develop Imetelstat
Johnson & Johnson (JNJ) Strikes $935 Million Deal With Geron Corporation (GERN) To Co-Develop Imetelstat
Bidness Etc.
JNJ
Geron
imetelstat
myelofibrosis
J&J Seeks FDA Approval for Schizophrenia Treatment
J&J Seeks FDA Approval for Schizophrenia Treatment
Yahoo/Zacks.com
JNJ
FDA
schizophrenia
paliperidone palmitate
antipsychotics
J&J, Boston Scientific $5B trial to begin Thursday
J&J, Boston Scientific $5B trial to begin Thursday
Seeking Alpha
JNJ
Boston Scientific
devices
Guidant
Geron Collaborates with J&J for Imetelstat
Geron Collaborates with J&J for Imetelstat
Yahoo/Zacks
Geron
JNJ
imetelstat
myelofibrosis
acute myelogenous leukemia
myelodysplastic syndrome
leukemia
Johnson & Johnson (JNJ) Wins Label Expansion Approval For Antipsychotic Drug
Johnson & Johnson (JNJ) Wins Label Expansion Approval For Antipsychotic Drug
Bidness Etc.
JNJ
Janssen
antipsychotics
Invega Sustenna
schizophrenia

Click here to subscribe to daily news headlines in your email inbox